BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15448024)

  • 1. Gene expression profiling of renal cell carcinoma.
    Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of gene expression analysis of renal cell carcinoma.
    Leppert JT; Pantuck AJ
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):293-9. PubMed ID: 16445381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms.
    Cheng L; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R
    Hum Pathol; 2009 Jan; 40(1):10-29. PubMed ID: 19027455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of renal cell carcinoma and clinical implications.
    Rogers CG; Tan MH; Teh BT
    Urology; 2005 Feb; 65(2):231-7. PubMed ID: 15708028
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles.
    Furge KA; Lucas KA; Takahashi M; Sugimura J; Kort EJ; Kanayama HO; Kagawa S; Hoekstra P; Curry J; Yang XJ; Teh BT
    Cancer Res; 2004 Jun; 64(12):4117-21. PubMed ID: 15205321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein expression profiles in renal cell carcinoma: staging, prognosis, and patient selection for clinical trials.
    Lam JS; Pantuck AJ; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):703s-708s. PubMed ID: 17255297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Introduction to the topic: molecular biological elucidation of renal cell carcinoma].
    Küfer R; Hautmann R
    Urologe A; 2006 Mar; 45(3):295-6. PubMed ID: 16482464
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular profiling of renal cancer: the journey to clinical application.
    Ribal MJ
    Eur Urol; 2011 May; 59(5):731-3. PubMed ID: 21296486
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic factors and molecular markers for renal cell carcinoma.
    Bui MH; Zisman A; Pantuck AJ; Han KR; Wieder J; Belldegrun AS
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):565-75. PubMed ID: 12113089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
    Yang XJ; Sugimura J; Tretiakova MS; Furge K; Zagaja G; Sokoloff M; Pins M; Bergan R; Grignon DJ; Stadler WM; Vogelzang NJ; Teh BT
    Cancer; 2004 Mar; 100(5):976-85. PubMed ID: 14983493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Staging and follow-up of renal cell carcinoma].
    Rouvière O; Brunereau L; Lyonnet D; Rouleau P
    J Radiol; 2002 Jun; 83(6 Pt 2):805-22, discussion 823-4. PubMed ID: 12218854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles correlate with the morphology and metastasis characteristics of renal cell carcinoma cells.
    Ami Y; Shimazui T; Akaza H; Uematsu N; Yano Y; Tsujimoto G; Uchida K
    Oncol Rep; 2005 Jan; 13(1):75-80. PubMed ID: 15583805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic renal cell carcinoma: many treatment options, one patient.
    Rini BI
    J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New trends in the diagnosis and treatment of renal cell carcinoma].
    Zisman A
    Harefuah; 2002 Aug; 141(8):713-7, 761. PubMed ID: 12222136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma.
    Seliger B; Lichtenfels R; Atkins D; Bukur J; Halder T; Kersten M; Harder A; Ackermann A; Malenica B; Brenner W; Zobawa M; Lottspeich F
    Proteomics; 2005 Jul; 5(10):2631-40. PubMed ID: 15892167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy.
    Cheng L; Williamson SR; Zhang S; Maclennan GT; Montironi R; Lopez-Beltran A
    Expert Rev Anticancer Ther; 2010 Jun; 10(6):843-64. PubMed ID: 20553210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.